This study provides the first morphological evidence of significant structural damage following high doses of enflurane alone and confirms previous findings of transient renal functional abnormalities following high dosage enflurane.
INTRODUCTION
Previous studies in an animal model have shown that high doses of the new anaesthetic en flu ran e (2-chloro 1, 1, 2-trifluoroethyldifluoro-methyl ether, ethranet) cause nephrotoxicity which is associated with similar peak serum inorganic fluoride concentrations to those following low doses of me~hoxyflurane . A controlled study of prolonged enflurane anaesthesia in normal man recently reported transient renal dysfunction (Mazze et al. 1977) . Case reports have suggested exacerbated renal dysfunction following enflurane anaesthesia in patients with renal disease (Loehning and Mazze 1974, Hartnett et al. 1974) .
The present study investigates renal functional and morphological changes following enflurane anaesthesia in Fischer 344 rats with mild renal dysfunction due to gentamicin treatment. It also examines the effect of pre-existing renal dysfunction on the serum concentration of the enflurane metabolite inorganic fluoride. METHODS Twenty-eight, inbred, male, eight month old, Fischer 344 rats, weighing 320 + 20g were placed in individual metabolic cages. Room temperature, lighting, diet and other environmental factors were controlled as previously described . Seven days were allowed for the animals to adapt to their cages, following which twenty-four hour urine samples were collected for six days. On the fourteenth day, rats were randomly divided into four groups and treated as follows:-Group r To receive distilled water 0.25 ml/kg (intraperitoneal) (i. p.), twice daily for nine days. Group II As above, followed by 1 MAC, enflurane for six hours on day twenty-three. Group III To receive gentamicin 25 mg/ kg (0.25 ml/kg) i.p., twice daily for nine days, followed by 1 MAC enflurane for six hours as above. Group IV To receive gentamlcme, as above, for nine days.
During Anaesthesia
Enflurane was administered simultaneously to Groups II and III in a closed perspex chamber using an "Enfluratec" vaporiser. The oxygen, carbon dioxide and enflurane concentrations in the chamber were simultaneously and continuously monitored using a "Centronic -200 MGA":j: mass spectrometer with a flexible probe which was placed just in front of the nostrils of each rat in sequence ( Figure  1 ). The enflurane concentration was also checked by injecting gas samples every half hour into a Varian Aerograph 1400 gas chromatograph fitted with a gas sampling loop and Poropak Q-column.
Rectal temperature was continuously monitored with Yellow Springs telethermometers and maintained between 34° -36°C with an electric blanket under the floor of the chamber. During the last three-quarter hour of anaesthesia 0.5 ml blood specimens were obtained from the tail of each rat and enflurane concentration was determined by direct injection into a gas chromatograph. Blood pH, pCO~ and FIGURE I.-Mass spectrometer recording of oxygen and carbon dioxide concentration in the anaesthesia chamber. In addition the mass spectrometer probe was repeatedly placed at the nostril of each animal to recflrd individual inspired enflurane concentration which is illustrated for one series of measurements for rat numbers 1 to 15. t MAC, minimum alveolar concentration of enflurane necessary to prevent movement in response to a surgical stimulus in 50% of animals 
Following anaesthesia
At the termination of anaesthesia the rats received 100% oxygen until fully awake, then were returned to their metabolic cages. Groups I and IV were placed in a common chamber during the anaesthetic period but received no anaesthesia and were returned to their cages at the same time as Groups Il and Ill. Twenty-four hour urine collections were resumed for two additional days. Tail blood samples were obtained during the experimental period, according to the schedule shown on Table 1 : Samples were collected near the completion of the control and treatment periods as well as at six hours after anaesthesia; blood was also obtained when half the animals of each group were sacrificed by stunning and decapitation, at twenty-four and forty-eight hours after anaesthesia. Micro-hematocrit determinations were carried out on a small sample of the blood and the remainder was allowed to clot, the serum decanted after centrifugation and frozen at -10 0 e.
Biochemical studies
Urine volume was measured for each 24 hour collection and a portion was frozen for subsequent analysis. Urine and serum determinations were carried out as follows: creatinine concentration by a Pierce's Creatinine II Rapid Stat Kit and a Gilford 300 Tt soectrometer and osmolalities by a Fiske OSTM osmometer. Serum urea nitrogen was determined using Pierce's BUN Rapid Stat Kit and serum inorganic F-by an Orion specific ion electrode, Model 94-09A. Urine excretions and clearances were calculated.
Morvhological studies
Kidney tissue was obtained immediately after sacrifice at 24 hours and 48 hours post anaesthesia by a method which has previously been shown to produce minimal interference with normal renal structure in control animals (Kosek et al. 1972) . The schedule for obtaining renal tissue is shown in Table 1 . Renal tissue was fixed in 2.5% Glutaraldehyde in O.lM sodium cacodvlate buffer and embedded in T AAB RESTN. Then 1 mM sections were cut from each pellet and stained with toluidine blue. Each block was trimmed down to an area containing a number of proximal convoluted tubule outlines (determined by light microscopy) and silver-gold ultrathin sections were cut for electron microscopv. Cutting was performed on an LKB ultra tome TIT and examination and (AFTER ACCLIMATISATION)  GROUPS  8  9  10  11  12 13  14  15  16  17  18  19 20 21  22 23 24  25   I   II   III IV
B B = Tail blood. collected E = Enfiurane anaesthesia st = Half the animals in the Group sacrificed by decapitation photography using a Corinth 275 electron microscope. All tissue was examined by a pathologist who was unaware of the study group from which it was obtained. Objective evaluation of the tissue was further aided by statistical comparisons of size and predominance of subcellular structures.
Epithelial cells of between 4 to 8 proximal convoluted tubules (P.C.T.) found on a random scan of a single section of each block were examined systematically as follows:
1. The number, size and type of lysosome was recorded. For the purposes of this work, single membrane bound bodies of uniform density, regardless of size, were regarded as primary lysosomes. (These are common in normal tubular epithelial cells of man and laboratory animals.) Similar bodies that contained any of a great variety of internal substructures (e.g. membrane like whorls), were regarded as secondary lysosomes. 2. The proportion of mitochondria which were normal, swollen or shrunk was estimated. 3. Cytoplasmic shrinkage or swelling, dilation of the endoplasmic reticulum and nuclear appearance were noted. Photographs were taken of all proximal convoluted tubules examined, and were printed at a final magnification of 2000-5000X Measurements of intracellular areas for comparison purposes were made by placing over the prints, transparent grids having a standard number of lines per unit length in each direction (and therefore a standard number of line intersections per unit area). The following relative measurements were made Anaesthesia and Intensive Care, Vol. VI, No. 4, Novembt!r, 1978 for each proximal convoluted tubule: total area of cells, from the basement membrane up to, but not including the brush border; total area of nuclei; total areas of primary and secondary lysosomes; individual areas of all nuclei and of largest primary and secondary lysosomes.
From the above measurements the following calculations were made: Areas of total, primary and secondary Iysosomes as a % of a total non-nuclear area; Average area of nuclei; Nuclear and non-nuclear areas as a % of total cell area.
Statistical methods
The mean value of each variable was calculated for each rat during the control period. Group means of the variables were determined for each day during the control and experimental period and compared using non-paired t tests. Since the groups did not differ significantly for any variable during the control period, further comparisons during treatment and post-treatment were made between the control group (Group I) and the other three groups and also among Groups 11-IV, using analysis of variance and non-paired t-tests. The analysis of variance indicated the validity of proceeding to t-test analysis which is presented.
RESULTS

Biochemical studies
During the pretreatment period (days 8-13) there were no significant differences, on a day to day basis among groups in any of the variables measured. Group means for each variable during the entire control period also showed no greater difference than would be expected due to chance alone (Table 3 and 4). 
The method of measurement of inorganic fluoride employed in this study had a lower limit of sensitivity of SJL mo1!L. 128.7 ± 6.9 113.5 ± 1.9 d 55.5 ± 0.9 f ,g 75.7 ± 2.3 f During the period of treatment prior to anaesthesia (days 14-22) there were significant increases in urine volume and decreases in urine osmolality in all rats treated with gentamicin (Groups III and IV), Table 4 , Figures 2, 3. There were also significant increases in serum creatinine in Groups III and IV (Table 3) . Although creatinine clearance tended to fall in rats treated with gentamicin, this was not significant on a group basis prior to anaesthesia (Table 5) ; however one rat in Group III had a Ccr which decreased from 0.9 ml/min in the control period to 0.5 ml/min on day 22.
At six hours following anaesthesia there were significantly greater increases in serum inorganic fluoride and urine volume in Group III animals compared to Group 11 (Figure 2 , Tables 3 and 4 ). There was a small but significant increase in Uosm V in Group 11 animals compared to Group III (Table 5) . Serum concentration of creatinine and urea nitrogen were elevated to a similar degree in Groups III and IV but not in Group 11. At this stage creatinine clearance was significantly reduced only in Group III (Enflurane plus gentamicin) (Table 5) .
During anaesthesia (day 23), animals in Group II and III maintained normal blood gases and pH. Inspired anaesthetic concentration, oxygen and carbon dioxide concentration in the breathing zone of each animal was similar ( Figure 1 ). Blood enflurane concentration was 11.4 + 0.7 mg % in Group 11 animals and 10.6 ± 0.7 mg % in Group III (Table 2) . Both at twenty-four an.d forty-eight hours post-anaesthesia, changes in urine volume and urine osmolality were significantly different in Group III compared to Group II or IV (Table  4- 5) . In particular at forty-eight hours, urine osmolality remained at a very low level of 776 ± 15 mOsm/kg in Group III compared to 1862 + 13 mOsm/kg in Group II and 1002 ± 15 mOsm/kg in Group IV (Table 4) .
By twenty-four hours postanaesthesia there was no significant difference in serum Fbetween Group II and Ill, although still elevated above control values for both groups.
Morphological studies
Since morphological changes at 24 and 48 hours were similar, data were pooled and are presented on a group basis:
CONTROL ANIMALS (GROUP I) Mitochondria
Occasional mitochondrial shrinkage, with expansion of the intercristal space was seen in almost all proximal convoluted tubules (P.C.T.'s) but was not accompanied by overall cell shrinkage or swelling. Slight mitochondrial swelling was seen in about one-third of proximal convoluted tubules but always involved only a very few organelles (Figure 4) ; this change was very different from the diffuse Anaesthesia and Intensive Care. Yol. YI. No. 4. November. 1978 swelling of mitochondria in animals of Groups II-IV (Figures 4 and 6) .
Lysosomes
The great majority were primary lysosomes which were round or oval in shape, with a maximum area of 10.5 sq /Lm. Secondary lysosomes were infrequent, but 29 were seen during detailed examination of the material. Of these 23 had a crystalloid, fibrous or indefinite sub-structure, while six had a myelinoid appearance. None was very large, the largest area being 4.70 /Lm 2 • The area of primary and secondary lysosomes as a percentage of non-nuclear area is shown in Table 6 .
The relative proportions and types of primary and secondary lysosomes represents the manifestation of normal subcellular turnover, in our material.
Nuclei
There was no evidence of nuclear damage. Average nuclear area per animal was 20.8 ± 1.66 p.m 2 • Individual nuclear areas ( Figure 5 ) varied, but most had an area between 10 and 30 m p.2, and only 15.5% had a nuclear area in excess of 30 p.m 2 • 2. ENFLURANE ONLY (GROUP II)
Mitochondria
Mitochondria showed slight but widespread swelling in 80% of P.C.T.'s. The swelling and the large number of organelles affected was quite different from anything seen in the control material and some of the cells involved showed shrinkage and increase of cytoplasmic density (See below).
Lysosomes
The size, number and appearance was mostly similar to that in the control material. However, whereas in control animals the percentage of Mitochondrial (m) lysosomal and nuclear (n) changes are more extensive than seen with gentamicin alone or enflurane alone. The majority of mitochondria are swollen. The proportion of secondary lysosomes (s) is much higher than in any other group and lysosomes are often very large with multiple myelinoid substructure in an apparently homogeneous base. primary lysosomes was significantly higher than secondary lysosomes, this difference was abolished in Group 11 animals (Table 6) .
Nuclei
There was a clear visual impression of nuclear swelling and lucency. The average nuclear area in each case was increased and when areas of individual nuclear outlines were expressed in terms of exact size categories the presence of swelling was confirmed ( Figure  5) . In comparison to Group I, the percentage of nuclei with areas between 10 and 30 p.m 2 fell from 72.4 to 56.4%, while those above 30 mp.2 rose from 15.5 to 29.9%.
In all cases some P.C.T. cells showed cytoplasmic as well as nuclear electron lucency and swelling. Some cells, however, showed definite cytoplasmic shrinkage, increased electron density, an.d dilatation and vesiculation of the endoplasmic reticulum, but without nuclear alterations. These two types of change were frequently seen in adjacent cells.
GENTAMICIN + ENFLURANE (GROUP Ill)
Changes in this group were qualitatively similar to those in the gentamicin alone group, but more extensive.
Mitochondria
Slight to moderate swelling occurred in 80% of P.C.T.'s and was more noticeable than in any other material. From about one-quarter up to the majority of mitochondria in anyone tubule were involved. The 'normal' parallel mitochondrial arrays at right angles to the tubular basement membranes were seen in only 30% of proximal convoluted tubules. These were often very large indeed (e.g. in excess of 50 p.m 2 ) with a multiple myelinoid substructure in an apparently homogeneous base. The proportion of secondary lysosome (ten times control) was significantly higher than in group I or 11, while the amount of primary lysosomal material in Group III was decreased to about one-third of the amount in control material (Table 6 ). A significant reduction in primary lysosomal material was present only in Group III animals.
Nuclei
There was a great variation in density, some being swollen, others shrunken. The percentage of outlines greater than 30 p.m2 in area was increased to 39.9%. Several nuclei showed chromatin margination, and in some this was extreme. The same nuclei had over-prominent nucleoli.
Severe cell shrinkage was seen in some cells. There were two tubules so necrotic that their type could not be determined with certainty. These showed nuclear chromatin margination, dissolution of the brush border, disrupted mitochondria, and enormous accumulations of secondary lysosomes (in one tubule constituting 21.6% of the non-nuclear area). In areas of apparently swollen cytoplasm there were very large numbers of free ribosomes possibly indicating dissolution of the rough endoplasmic reticulum.
In summary there was significant electron microscopic evidence of altered cell function as evidenced by lysosomal, cytoplasmic and nuclear alteration in the P.C.T. of rats following the administration of enflurane or gentamicin. When the two agents were administered together the overall effect was greater than with either agent alone.
GENTAMICIN ONLY (GROUP IV)
Changes were similar to those detailed in previous reports .
Mitochondria
Mitochondria showed slight but extensive swelling involving up to one-third of all the mitochondria (Figure 6) .
Lysosomes
There was a great increase in the number and size of secondary lysosomes (Table 6) . Sometimes giant forms were present and many showed a complex, multiple-myelinoid substructure. The number of primary lysosomes decreased while the number of secondary Iysosomes increased to 8.9% (Table 6 ). However, unlike Group III the reduction in primary lysosomes was not statistically significant.
Nuclei
Many had a swollen, electron lucent, appearance similar to that in enflurane treated rats. The number of nuclear outlines with an area between 10 and 30 sq m was decreased from 72.4 to 58.5% ( Figure 5 ) while the number with areas greater than 30 sq m increased from 15.5 to 33.7% (more than a doubling).
One case in this category differed from the others in onc respect: large complex secondary Iysosomes were not seen but although the majority of Iysosomes were small they were secondary type. These small secondary Iysosomes exhibited a series of appearances suggestive of transformation of damaged mitochondria, with early detachment and aggregation of cristal material ending in small myelinoid bodies whose structure suggested that they were precursors which by fusion form the large complex myelinoid bodies seen in other cases in this category.
DISCUSSION
Enflurane anaesthesia was followed by increased renal functional and histological abnormalities when the anaesthetic was administered to animals with pre-existing renal impairment (Figures 1-6, Tables 3-6 ). In addition the peak serum concentration of inorganic fluoride following enflurane anaesthesia was significantly higher in animals with pre-existing renal impairment (Group Ill, 43.9 ± 1.5 fLmol/l) compared to animals receiving enflurane alone (Group Il, 34.5 ± l.g I~mol/I); this was associated with a low creatullne clearance in Group III animals (Tablc 5).
It is thus likely that the higher serum Fin Group III animals was due to pre-existing impairment of renal function and reduced fluoride excretion, since F-clearance is approximately half creatinine clearance.
A previous study in patients with low creatinll1e clearance (C cr ) claimed that serum F-was not elevated to a clinically significant degree (Carter et al. 1976 ). However, the values measured at 24 hours were significantly higher in patients with low C cr compared to those with normal C n • Neither blood nor alveolar concentration of enflurane was measured so it is difficult to determine if equivalent doses were administered to each group. However, average dosage appears to have been close to two hours at 0.5 to 0.7 MAC (i.e. 1.0 to 1.4 MAC hours) with a peak serum F-of 13 fLmol/1 in patients with normal Ccr and 19 fLmol/1 in patients with reduced C cr • The latter figure would be expected in normal patients after four hours of enflurane at ~-MAC (Lowry et al. 1977) . The elevation in serum F-in patients reported by Carter et al. (1976) is in keeping with the findings of the present study. Their supposition that elevation of serum F-to a mean of 19 fLmol/1 (range 14.5 to 26) was clinically harmless in a compromised kidney, is not supported by other recent work. It has previously been thought that the threshold for F-renal toxicity was approximately 50 fLmol/1 Mazze 1973, Cousins et al. 1974) . However more recently transient polyuria has been demonstrated in the animal model at serum F-of 40 fLmol/l and in man at serum Fof 30-40 fLmol/1 (Mazze et al. 1977 ). Furthermore Roman et al. (1977) have reported that more prolonged exposure of the kidney to F-(such as might occur with reduced C cr ) results in toxicity at serum F-as low as 20 (-tmol/I.
In the present study renal functional abnormalities were detected following enflurane alone (Group /l) at serum F-of 34.5 -+-1.8
I~mol/l and this was accompanied by significant abnormalities in morphological structure (Table 3 . The functional changes were limited to polyuria with a significant reduction in urinary osmolality in the face of a normal serum osmolality and a slight increase in osmolal excretion. The morphological changes were mild but included consistent mitochondrial swelling and increased numbers of secondary lysosomes and also Anaesthesia and In/ens; ,'e Care, Vol. VI, No. 4, November. 1978 nuclear swelling (Table 6, . It could be argued that these changes may be due to the non-specific stress of pro~onged anaesthesia. However, previous studies in this model of larger doses of halothane, 4.5 MAC hours (Mazze, Cousins and Kosek 1972) and much larger doses of isoflurane, 15 MAC hours (Cousins, Mazze and Barr 1973) failed to reveal any functional or histological abnormalities. This has b~en confirmed in studies of renal function in man at halothane doses of up to 8 MAC hours and isoflurane doses of up to 7 MAC hours .
Animals treated with gentamicin prior to enflurane anaesthesia, Group Ill, had much more marked renal functional abnormalities compared to Group Il. These were manifested by a large increase in urine volume to in excess of 2.5 times control values and very low urine osmolality of almost 1/3 control values despite a minimal change in osmolal excretion (Figures 2-3 ). In addition, creatinine clearance was reduced to approximately half normal values. Morphological changes were highlighted by more extensive mitochondrial swelling than in any other group and a large number of multilobed secondary lysosomes as well as nuclear swelling (Table 3 . This overall picture was indicative of extensive damage to subcellular structure.
The impairment of renal function due to gentamicin alone (Group IV) in the present study was mild but significant and was similar to that previously reported . Functional impairment was verified by quantitative documentation of abnormalities in renal morphology which were more extensive than the functional abnormalities had indicated. This of course is not unexpected since it is necessary to produce considerable damage to renal functional tissue before a reduction in creatinine clearance is detected. Even in the presence of this degree of renal functional and structural abnormality enflurane was shown to be significantly more nephrotoxic than in the presence of normal renal function.
Precise control of anaesthetic dosage has permitted valid comparison of peak serum Fin normal compared to damaged kidneys and leaves no doubt that reduced renal function may result in a higher serum F-and a greater potential nephrotoxicity at the same blood concentration and duration of administration viz, same dose in MAC hours .
Anaesthesia and Intensive Care, Vol. VI, No. 4, November, 1978 The implications of the present study for the clinical use of enflurane must be considered in the light of the validity of the animal model employed. It has previously been reported that this model, the Fischer 344 rat, metabolises another fluorinated anaesthetic methoxyflurane, in a similar manner to man (Mazze, Trudell and Cousins 1971, Mazze, Cousins and Kosek 1972) . In addition, in both man and the model the functional renal abnormalities were similar, were related to the dose of anaesthetic and in turn to the resultant serum concentration of F-with a similar toxic threshold (Couins and Kosek 1972) . Evidence has been presented that methoxyflurane and enflurane share F-as a common toxic metabolite, in that similar degrees of renal dysfunction occurred following both agents at almost identical serum F- . Further support to this hypothesis was that the serum F-declined rapidly following enflurane and this was paralleled by a rapid return to normal renal function whereas both parameters returned to baseline slowly after methoxyflurane . Prior to the present study there has been no direct evidence that enflurane alone is capable of causing renal structural damage. The ultra structural changes reported following enflurane alone in the present study are essentially the same as those previously reported following methoxyflurane (Mazze et al. 1972) . It is reasonable to regard the lesion characteristic of enflurane nephrotoxicity as being the same as methoxyflurane, being directly due to F-and having a similar threshold . Thus the justification for extrapolation from the model to man for methoxyflurane can reasonably be applied to enflurane also. This is supported by the finding of pitressin resistant polyuria following enflurane at a serum F-of approximately 40 ",mol/l in both the model and also man (Mazze et al. 1977) .
Controlled studies of the metabolism of enflurane and its renal effects in man indicate that serum F-is approximately 20 ",molll after doses of up to 4 hours at 1 MAC (4 MAC hours) (Cousins et al. 1976 , Lowry et al. 1977 with no associated renal dysfunction. Although initial studies failed to reveal a relationship between enflurane dose and serum F- (Cousins et al. 1976 ) more precise control of dosage subsequently permitted the definition of a clear dose-response relationship (Lowry et al. 1977) . Thus it would be expected that the renal dysfunction seen at high enflurane dose in the model would also be seen at high dose in man. This has only recently been confirmed in volunteer studies at doses of enflurane in the vicinity of 10 MAC hours (Mazze et al. 1977) . It is not likely that such high doses would be reached in the clinical setting so that the potential for enflurane nephrotoxicity probably resides in other additive factors in a manner similar to that previously delineated for Fnephrotoxicity in association with the low dosage methoxyflurane Mazze 1973, Cousins et al. 1974) . In the animal model enzyme induction does not appear to increase nephrotoxicity of enflurane, in contrast to the increased metabolism of methoxyflurane and parallel increase in nephrotoxicity ). It has subsequently been shown that enflurane's metabolism was increased in vitro (Greenstein et al. 1975) ; however in vivo it appeared that substrate rather than enzyme was rate limiting and the agent was too rapidly cleared to enable enzyme induction to exert a significant effect on serum F-following enflurane .
Early concern about the potential nephrotoxicity of enflurane in the presence of pre-existing renal impairment arose from a case report of a patient with renal impairment which appeared to be exacerbated by enflurane anaesthesia (Loehnig and Mazze 1974) and a further patient who developed oliguric renal failure following enflurane anaesthesia (Hartnett et al. 1974) . However in the latter case there were a number of other possible contributing factors. The present study provides direct evidence that enflurane's nephrotoxicity is significantly increased in the presence of moderate pre-existing renal impairment and recommends its avoidance in such patients. Since enflurane is so rapidly cleared from the body it is less likely that another nephrotoxic drug would increase enflurane's nephrotoxicity if commenced either during or after enflurane anaesthesia; further data are required to define this risk. However the present study indicates that enflurane shouLd not be used in patients who have been receiving nephrotoxic drugs prior to operation. Previous studies have demonstrated that the other fluorinated hydrocarbon anaesthetics halothane and isoflurane are not metabolished to sufficient F-to pose a danger of nephrotoxicity under the circumstances studied to date . At the present time methoxyflurane and enflurane must be regarded as the two modern inhalation agents with potential for metabolite induced nephrotoxicity. The most commonly used fluorinated anaesthetic halothane, is still under investigation for its hepatotoxic potential. However, a likely mechanism is emerging which appears to be related to metabolism and the superimposition of additive factors (Brown and Sipes 1977) as is the case for the renal toxicity of methoxyflurane and enflurane.
